NCT00067210

Brief Summary

Doctors use cooling of the brain to help stop seizures. This procedure is usually accomplished through surgery. Cooling of the face and scalp may also cool the brain, avoiding the need for surgery. The purpose of this study is to assess a head-neck cooling device that the patient can wear. Researchers will determine whether the device can change the frequency of seizures in people with epilepsy. Study participants must be 21 years of age or older and must experience seizures that occur once a week on a regular basis. Participants will be asked to keep a detailed seizure diary for a 12-week period before the date of the first cooling session. For each of the four cooling sessions, participants will be admitted to the hospital overnight. They will undergo a physical and neurological exam and an EEG (electroencephalogram). They will also swallow a temperature-sensor pill. Participants will have one 60-minute cooling session once a week for 4 weeks. Investigators will paste temperature-sensing electrodes on the scalp, forearm, abdomen, and leg. Participants will then be fitted with the cooling unit and the session will begin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Aug 2003

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 11, 2003

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 12, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 13, 2003

Completed
3.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2007

Completed
Last Updated

July 2, 2017

Status Verified

June 13, 2008

First QC Date

August 12, 2003

Last Update Submit

June 30, 2017

Conditions

Keywords

BrainEpilepsyCoreTemperature

Outcome Measures

Primary Outcomes (1)

  • Identify optimal cooling parameters,namely duration and frequency of cooling for reducing seizure frequency.

Interventions

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A minimum of one documented seizure of any type per a 1-week period.
  • years or older, and able to cooperate with the cooling procedures.
  • On a stable antiepileptic drug (AED) regimen, as determined by history and by AED plasma levels as measured in the CC OPD.
  • The ability to maintain a daily seizure calendar, either independently or with help from a family member.
  • No history of intestinal problems or history of intestinal surgery.
  • Must be able to swallow medication in capsule form.

You may not qualify if:

  • Female patients who are pregnant.
  • Those patients under 21 years of age.
  • Those patients who may have difficulty swallowing a large capsule, or describing their feelings and experiences related to the cooling sessions.
  • Those patients with a history of intestinal problems or intestinal surgery
  • Those patients with progressive neurological disorders
  • Those sensitive to coldness
  • History of severe 'ice-cream' headache

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (1)

  • Cabanac M. Selective brain cooling in humans: "fancy" or fact? FASEB J. 1993 Sep;7(12):1143-6; discussion 1146-7. doi: 10.1096/fasebj.7.12.8375612.

    PMID: 8375612BACKGROUND

MeSH Terms

Conditions

EpilepsySeizures

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 2
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

August 12, 2003

First Posted

August 13, 2003

Study Start

August 11, 2003

Study Completion

May 22, 2007

Last Updated

July 2, 2017

Record last verified: 2008-06-13

Locations